{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 448210005
| IUPAC_name = (2a''S'',2b''R'',3''S'',4''S'',6''S'',8a''R'',10''S'',11a''S'',11b''R'',13a''R'')-2a-(acetyloxy)-6-{[(2''R'',3''S'')-3-[(''tert''-butoxycarbonyl)amino]-3-(3-fluoropyridin-2-yl)-2-hydroxypropanoyl]oxy}-10-[(dimethylamino)methyl]-4-hydroxy-7,11b,14,14-tetramethyl-2a,2b,3,4,5,6,8a,11a,11b,12,13,13a-dodecahydro-2''H''-4,8-methano[1,3]dioxolo[3,4]cyclodeca[1,2-''d''][1]benzoxet-3-yl benzoate
| image = Tesetaxel.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Investigational
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 333754-36-2
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 6918574
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = UG97LO5M8Y
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 5293771

<!--Chemical data-->
| C=46 | H=60 | F=1 | N=3 | O=13 
| molecular_weight = 881.98 g/mol
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI=1S/C46H60FN3O13/c1-24-28(58-40(54)34(52)33(32-27(47)17-14-20-48-32)49-41(55)63-42(3,4)5)21-46(56)38(61-39(53)26-15-12-11-13-16-26)36-44(8,19-18-29-45(36,23-57-29)62-25(2)51)37-35(31(24)43(46,6)7)59-30(60-37)22-50(9)10/h11-17,20,28-30,33-38,52,56H,18-19,21-23H2,1-10H3,(H,49,55)/t28-,29+,30+,33-,34+,35+,36-,37+,38-,44+,45-,46+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = MODVSQKJJIBWPZ-VLLPJHQWSA-N
| smiles = CC1=C2[C@@H]3[C@H]([C@@]4(CC[C@@H]5[C@]([C@H]4[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C6=C(C=CC=N6)F)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)C)O[C@@H](O3)CN(C)C
}}

'''Tesetaxel''' ('''DJ-927''') is a drug being investigated for [[chemotherapy]] of various types of cancer, including [[breast cancer]],<ref>{{ClinicalTrialsGov|NCT01609127|Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer}}</ref> [[gastric cancer]],<ref>{{ClinicalTrialsGov|NCT01348009|Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer}}</ref> and other solid tumours.<ref>{{Cite journal 
| last1 = Saif | first1 = M. W. 
| last2 = Sarantopoulos | first2 = J. 
| last3 = Patnaik | first3 = A. 
| last4 = Tolcher | first4 = A. W. 
| last5 = Takimoto | first5 = C. 
| last6 = Beeram | first6 = M. 
| doi = 10.1007/s00280-011-1639-3 
| title = Tesetaxel, a new oral taxane, in combination with capecitabine: A phase I, dose-escalation study in patients with advanced solid tumors 
| journal = Cancer Chemotherapy and Pharmacology 
| volume = 68 
| issue = 6 
| pages = 1565â€“1573 
| year = 2011 
| pmid = 21547572 
| pmc = 
}}</ref>

==References==
{{reflist}}

{{Chemotherapeutic agents}}


[[Category:Mitotic inhibitors]]
[[Category:Benzoates]]
[[Category:Carbamates]]
[[Category:Pyridines]]
[[Category:Organofluorides]]
[[Category:Alcohols]]
[[Category:Ketones]]
[[Category:Acetate esters]]
[[Category:Taxanes]]
[[Category:Tert-butyl compounds]]


{{antineoplastic-drug-stub}}